Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2000
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009657A2 Methods of modulating of angiogenesis
02/24/2000WO2000009562A1 Novel cleaved fragments of fibrinogen
02/24/2000WO2000009561A1 Monoclonal antibody inhibitor of gm-csf, il-3, il-5 and other cytokines, and uses thereof
02/24/2000WO2000009560A2 Generation of modified molecules with increased serum half-lives
02/24/2000WO2000009559A1 Method for producing a balanced antibody composition and for purifying constituents of biological liquids
02/24/2000WO2000009550A1 Vanadate resistance glycosylation 4 gene
02/24/2000WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
02/24/2000WO2000009541A1 nrdE
02/24/2000WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions
02/24/2000WO2000009532A1 Methods and compositions for modulating transcription by use of antibodies to transcription factors
02/24/2000WO2000009487A1 Near infrared chemiluminescent acridinium compounds and uses thereof
02/24/2000WO2000009164A1 Antibodies for use in targeted and temporary treatment of humans and animals
02/24/2000WO2000009160A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
02/24/2000WO2000009151A1 Regulation of dendritic cell trafficking
02/24/2000WO2000003024A3 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon
02/24/2000WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses
02/24/2000WO1999058692A3 Human apoptosis associated proteins
02/24/2000WO1999058684A3 Compounds from moraxella catarrhalis
02/24/2000WO1999042586A3 Exo1 and exo2, exocytotic proteins
02/24/2000DE19938394A1 Immunoadsorber for removing endotoxins from fluids uses avian endotoxin antibodies
02/24/2000DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis
02/24/2000CA2349852A1 Method for recovering proteins from the interstitial fluid of plant tissues
02/24/2000CA2341029A1 Generation of modified molecules with increased serum half-lives
02/24/2000CA2340116A1 Antibodies for use in targeted and temporary treatment of humans and animals
02/24/2000CA2340091A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
02/24/2000CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
02/24/2000CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
02/24/2000CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions
02/24/2000CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000CA2339338A1 Vanadate resistance glycosylation 4 gene
02/24/2000CA2339337A1 Drug targets in candida albicans
02/24/2000CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
02/24/2000CA2339088A1 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists
02/24/2000CA2339048A1 Monoclonal antibody against canine trypsin
02/24/2000CA2338386A1 Proteases and associated proteins
02/24/2000CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
02/23/2000EP0980436A1 Increased production of proteins by using chaperone-like proteins
02/23/2000EP0980435A1 Human prohormone convertase 4
02/23/2000EP0980432A1 Chimeric opg polypeptides
02/23/2000EP0980431A1 Antimicrobial peptide
02/23/2000EP0980429A2 Human toll-like receptor proteins, related reagents and methods
02/23/2000EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes
02/23/2000EP0980426A1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs)
02/23/2000EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
02/23/2000EP0980387A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
02/23/2000EP0980259A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
02/23/2000EP0980258A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
02/23/2000EP0980251A1 Tissue factor for influencing blood vessel formation
02/23/2000EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES
02/23/2000CN1245534A Mammalian cell surface antigens and relating reagents
02/23/2000CN1245533A Mammalian chemokines
02/23/2000CN1245503A Oil bodies and associated proteins as affinity matrices
02/23/2000CN1245502A DNA encoding lepidopteran-active delta-endotoxins and its use
02/23/2000CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B
02/22/2000US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents
02/22/2000US6028174 Method of diagnosing and treating gliomas
02/22/2000US6028173 Amino acid sequence of polypeptide involved in axon outgrowth
02/22/2000US6028171 Class I MHC modulation of surface receptor activity
02/22/2000US6028059 Methods for modulating protein function in cells using intracellular antibody homologues
02/22/2000US6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis
02/22/2000US6027934 Nucleic acid and vectors encoding an immunodominant fragment of a unique protein antigen originally derived from trypanosoma brucei rhodesiense organisms can induce immunoprotection such as against trypanosomes, leishmania
02/22/2000US6027933 Surface expression libraries of heteromeric receptors
02/22/2000US6027927 Human trk receptors and neurotrophic factor inhibitors
02/22/2000US6027922 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use
02/22/2000US6027917 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
02/22/2000US6027906 Dna molecules coding for the said penicillin binding protein (pbp) variants, as well as vectors containing them; assaying and designing therapeutically useful compounds which have high affinity to pbp
02/22/2000US6027905 Methods for the detection of cervical cancer
02/22/2000US6027903 Kit for detecting analyte indicative of type I collagen resorption in vivo
02/22/2000US6027896 Providing a prognosis in subjects previously diagnosed with alzheimer's by identifying the apolipoprotein e type isoforms; then providing prognosis based on the presence or absence of an apolipoprotein e type 4 (apoe4) isoform
02/22/2000US6027887 Screening for preneoplastic/neoplastic disease using a nucleic acid based assay to determine whether mn oncogene expression is present in a vertebrate; and if present, determining if vertebrate is at risk of neoplastic disease
02/22/2000US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders
02/22/2000US6027733 Method for generating saccharide fragments
02/22/2000US6027729 An isolated polypeptide comprising an amino acid sequence of at least 12 contiguous amino acids encoded by a non-a, non-b hepatitis virus, i.e., hepititis c, genome; managing infection spread; medical diagnosis; evaluation of library
02/22/2000US6027727 Inducing transient infertility in a mammal by administering a dose of recombinant zona pellicida proteins from a cat, cattle or cynomolgous monkey and human to stimulate antibody production; vaccines
02/22/2000US6027725 Multivalent antigen-binding proteins
02/22/2000US6027720 G-CSF conjugate
02/22/2000CA2093521C Detection of diarrheogenic shellfish toxins
02/22/2000CA2091882C Gene therapy for cystic fibrosis
02/22/2000CA2063303C Preparation of virus-free immunoglobulins
02/22/2000CA2003455C Immunotherapy involving cd28 stimulation
02/22/2000CA1340908C Methods of producing secreted receptor analogs and biologically active peptide dimers
02/19/2000CA2245340A1 Traf4-associating protein
02/17/2000WO2000008463A2 Immunoadsorber for removing endotoxins
02/17/2000WO2000008210A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
02/17/2000WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
02/17/2000WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a)
02/17/2000WO2000008181A2 Chp polypeptide, a ligand of pak65
02/17/2000WO2000008180A2 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
02/17/2000WO2000008179A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases
02/17/2000WO2000008178A2 Murine dna molecules encoding polypeptides having kinase functions
02/17/2000WO2000008177A2 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000WO2000008173A1 Identification and functional characterization of a novel ribosomal s6 protein kinase
02/17/2000WO2000008172A1 Method to alter the fatty acid metabolism in plants
02/17/2000WO2000008171A1 N-acetylglycosaminyl transferase genes
02/17/2000WO2000008160A2 A plant disease resistance signalling gene: materials and methods relating thereto
02/17/2000WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000WO2000008146A2 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents
02/17/2000WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3